The chronic myelogenous leukemia (CML) treatment market encompasses the various drugs and therapies used to treat patients with CML, a type of cancer that affects the white blood cells. The market includes both branded and generic drugs, as well as stem cell transplantation and other treatment options. The market is driven by the increasing prevalence of CML worldwide and the development of...